Hutch News

Hutch News

Stories tagged 'immunotherapy'

Immunotherapy strategy for ovarian cancer aims to rewire a ‘kill switch’ to ramp-up signal

T cells bearing a new engineered protein boost immunotherapy’s effectiveness in laboratory models of AML, ovarian, pancreatic cancers

April 16, 2018 | By Rachel Tompa / Fred Hutch News Service

In an effort to improve the efficacy of immunotherapy for solid tumors, Fred Hutch researchers have engineered a new type of protein that can rewire a 'kill switch' to stimulate T cells' activity instead.

View story >


How does leukemia escape from immunotherapy?

New tech enables deep dive into mysterious results, sets stage for future improvements

April 16, 2018 | By Susan Keown / Fred Hutch News Service

“We don’t stop asking what we can do better”: Fred Hutch researchers delve into failures to learn how to improve an experimental cancer immunotherapy.

View story >


Data drives life sciences boom in Seattle

Hutch leaders, entrepreneurs stress importance of partnerships at Life Science Innovation Northwest conference

March 30, 2018 | By Sabin Russell and Diane Mapes / Fred Hutch News Service

At a conference in Seattle, health researchers and entrepreneurs said partnerships are key as bioscience converges with data science and computer technology.

View story >


Society for Immunotherapy of Cancer to honor Dr. Phil Greenberg

Immunology research leader named 2018 recipient of Richard V. Smalley, M.D., Memorial Award and Lectureship

March 23, 2018

On March 22, the Society for Immunotherapy of Cancer announced Fred Hutch's Dr. Philip Greenberg as the 2018 recipient of the Richard V. Smalley, M.D., Memorial Award and Lectureship, the society’s highest honor.

View story >


Dr. Phil Greenberg named 2018 Leader in Health Care

Seattle Business Magazine honors cancer immunotherapy pioneer for his work on T-cell therapy

March 2, 2018 | By Susan Keown / Fred Hutch News Service

Seattle Business Magazine honors Fred Hutch cancer immunotherapy pioneer Dr. Phil Greenberg with 2018 Leaders in Health Care Gold Award for Achievement in Medical Research.

View story >


Meet Global Oncology's deputy program head

Key early experiences shaped Dr. Thomas Uldrick's path toward HIV-associated cancers, global health

Feb. 22, 2018 | By Mary Engel / Fred Hutch News Service

Dr. Thomas Uldrick brings expertise in HIV-related cancers and experience in — and a passion for — developing clinical trials to his new position at Fred Hutch Global Oncology.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.